According to National Programme for Control of Blindness, glaucoma is the third major cause of blindness in India. A progressive condition it has the potential to lead to blindness.Dr. Agarwal’s Eye Hospital, India’s leading eye care chain, launched Single pass four throw pupilloplasty, an innovative treatment modality for glaucoma, in Kolkata. A medical breakthrough, Single pass four throw pupilloplasty was invented by Dr. Amar Agarwal, Chairman and Managing Director, Dr. Agarwal’s Group of Eye Hospitals. One-of-its-kind, the technique in a effective method to treat closed angle glaucoma. The treatment technique can be used in both early and advanced closed angle glaucoma cases.
Talking about the Single pass four throw pupilloplasty, Dr. Swati Bhattacharya, Medical Director, Dr. Agarwal’s Eye Hospital said, “The biggest advantage of Single pass four throw pupilloplasty is that unlike the conventional methods like medication, laser and surgery, it addresses the root cause of the condition. SFT opens up the angle structures thereby allowing the aqueous (fluid in the eye) to flow freely which otherwise would have stayed within and build the pressure in the eye. The other merit is that it is simple, effective and safe.”
In Single pass four throw pupilloplasty (SFT), the iris position is corrected by releasing the iris from the angles where the fluid drains. This new method of pulling the iris (the brown tissue) from the angle from where it has been attached to the centre creates clear angles. By this method, the iris is prevented from blocking the aqueous or fluid flow inside the eye which is necessary to maintain pressure. The method has been found to give better outcomes as compared to laser treatment. It also serves as an added advantage in treating patients with high eye pressure due to closed angles by iris tissue.
“The surgery is very simple and takes only 10 to 15 minutes. The first case under this innovative treatment was done in April this year and since then we have successfully treated as well as delivered clear vision to more than 40 glaucoma patients at our hospitals in Chennai, Karnataka and Hyderabad.” added, Dr. Chhanda Ghosh, Surgeon – Cataract & Retina, Dr. Agarwal’s Eye Hospital.
Elaborating about the prevalence of glaucoma in the city, Dr. Pallavi Raj – Glaucoma Expert, said, “After cataract, Glaucoma is second most common eye disease observed in the city. Out of every 10 patients who consult us, 2 of them suffer from glaucoma. As damage caused by glaucoma is irreversible early detection is the only solution to prevent the morbidity the condition can bring.”
The introduction of SFT as a treatment for Glaucoma has not only come as a relief for patients suffering from Glaucoma but also as a boon for the eye care industry as a whole. It is an accepted treatment for adults as well as children who suffer from the condition. A onetime surgical intervention it does not require further medication or prolonged post treatment care. As the cause is addressed, the treatment ensures that glaucoma doesn’t relapse.